These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5705781)

  • 1. Antilymphocytic leukemic serum and chemotherapy in the treatment of murine leukemia.
    Miller DG; Moldovanu G; Kaplan A; Tocci S
    Cancer; 1968 Dec; 22(6):1192-8. PubMed ID: 5705781
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. IX.
    Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
    Cancer Chemother Rep 2; 1971 Apr; 2(1):65-133. PubMed ID: 5565539
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive drugs. I.
    Br Med J; 1970 Dec; 4(5736):663-5. PubMed ID: 4922755
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of murine leukemia chemotherapy according to the immune state: reconsideration of correlations between chemotherapy, tumour cell killing, and survival time.
    Mathé G; Halle-Pannenko O; Bourut C
    Recent Results Cancer Res; 1977; (62):9-12. PubMed ID: 304590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antilymphocytic serum (antilymphocyte globulin) in the management of transplants].
    Gieldanowski J
    Wiad Lek; 1970 Nov; 23(22):1971-7. PubMed ID: 4395160
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined effects of chemotherapy and immunity against leukemia L1210 in DBA-2 mice.
    Mihich E
    Cancer Res; 1969 Apr; 29(4):848-54. PubMed ID: 4887203
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined therapy of L1210 leukemia with Damvar and cytostatics.
    Pujman V; Cernochová S
    Neoplasma; 1979; 26(5):521-3. PubMed ID: 522924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The feasibility of prolonging the visability of allotransplants by using antilymphocytic and antithrombocytic sera].
    Khundanov LI; Verbitskiĭ MSh; Artsimovich NG; Kipervasser EM; Lagutina NIa
    Probl Gematol Pereliv Krovi; 1972 Feb; 17(2):42-50. PubMed ID: 4558981
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of 2,2'(methylenediimino)bis-1,3,4-thiadiazole (NSC-143019) on tumor growth and immune responses in mice.
    Matsumoto T; Ootsu K; Okada Y
    Cancer Chemother Rep; 1974; 58(3):331-44. PubMed ID: 4152218
    [No Abstract]   [Full Text] [Related]  

  • 10. Modification of tumor regression by immunologic means.
    Mihich E
    Cancer Res; 1969 Dec; 29(12):2345-50. PubMed ID: 5387264
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of chemotherapy on the kinetics of leukemic cell behavior.
    Skipper HE
    Cancer Res; 1965 Oct; 25(9):1544-50. PubMed ID: 5861078
    [No Abstract]   [Full Text] [Related]  

  • 12. Antilymphocytic serum and tumour dissemination.
    Hellmann K; Hawkins RI; Whitecross S
    Br Med J; 1968 Jun; 2(5604):533-5. PubMed ID: 5724453
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipid-soluble derivatives of 6-mercaptopurine.
    Temple C; Kussner CL; Montgomery JA
    J Med Chem; 1968 Jan; 11(1):41-4. PubMed ID: 5637187
    [No Abstract]   [Full Text] [Related]  

  • 14. Nucleic acids. 11. Synthesis of 5'-esters of 1-beta-D-arabinofuranosylcytosine possessing antileukemic and immunosuppressive activity.
    Gish DT; Kelly RC; Camiener GW; Wechter WJ
    J Med Chem; 1971 Dec; 14(12):1159-62. PubMed ID: 5116227
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticancer activities of methanesulfonic acid esters of aminoglycols against mouse leukemia L-1210.
    el-Merzabani MM; Sakurai Y
    Gan; 1967 Apr; 58(2):199-201. PubMed ID: 6075181
    [No Abstract]   [Full Text] [Related]  

  • 16. The chemotherapy of human and animal acute leukemia.
    Goldin A; Sandberg JS; Henderson ES; Newman JW; Frei E; Holland JF
    Cancer Chemother Rep; 1971 Nov; 55(4):309-505. PubMed ID: 4945857
    [No Abstract]   [Full Text] [Related]  

  • 17. Antigenic changes associated with resistance to methotrexate and 6-mercaptopurine in L1210 ascites lymphoma.
    Calman NS; Eng B; Slater LM; Wallerstein H
    J Natl Cancer Inst; 1974 Mar; 52(3):997-8. PubMed ID: 4826575
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunosuppressive methods and antilymphocytic serum.
    Pichlmayr R
    Stud Gen (Berl); 1970; 23(4):344-52. PubMed ID: 4988857
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased lifespan using the priming dose schedule design in carbazilquinone (NSC-134679) treatment of mouse leukemia L1210.
    Straus MJ; Goldin A
    Cancer Chemother Rep; 1972 Feb; 56(1):19-23. PubMed ID: 5030804
    [No Abstract]   [Full Text] [Related]  

  • 20. [Induction of tolerance of heterologous protein in therapy with antilymphocytic globulin in man].
    Tilz GP
    Med Klin; 1972 Mar; 67(12):410-3. PubMed ID: 4112374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.